Lushang Freda Pharmaceutical Co.,Ltd. (SHA:600223)

SHA:600223 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,751	2,948	1,734	4,318	5,139	5,074
Cash & Short-Term Investments	2,751	2,948	1,734	4,318	5,139	5,074
Cash Growth	-6.54%	70.04%	-59.85%	-15.97%	1.27%	34.82%
Accounts Receivable	540.45	511.85	599.06	428.31	306.23	447.69
Other Receivables	33.91	21.22	3,052	1,307	1,226	400.42
Receivables	574.36	533.07	3,652	1,740	1,532	848.11
Inventory	483.18	558.71	525.44	46,047	48,204	46,665
Prepaid Expenses	-	-	-	491.91	608.15	449.64
Other Current Assets	159.55	104	73.85	3,032	3,187	6,080
Total Current Assets	3,968	4,144	5,984	55,629	58,670	59,117
Property, Plant & Equipment	1,179	1,192	1,203	1,382	1,345	1,201
Long-Term Investments	185.31	168.53	191.76	926.97	874.1	633.52
Goodwill	153.74	153.74	153.74	155.59	160.33	164.31
Other Intangible Assets	163.83	163.22	148.7	196.5	210.1	215.7
Long-Term Deferred Tax Assets	28.26	29.82	23.66	105.04	101.25	105.42
Long-Term Deferred Charges	83.5	91.11	53.96	52.34	40.51	44.1
Other Long-Term Assets	68.87	58.73	58.26	26.22	13.92	17.53
Total Assets	5,831	6,000	7,818	58,474	61,415	61,499
Accounts Payable	312.06	413.35	452.98	9,266	8,694	8,388
Accrued Expenses	53.71	136.53	127.32	1,003	948.47	727.27
Short-Term Debt	181.06	212.12	705.22	2,270	3,219	4,303
Current Portion of Long-Term Debt	10.93	12.51	790.34	3,222	2,307	2,738
Current Portion of Leases	-	9.21	8.16	5.68	1.99	-
Current Income Taxes Payable	26.15	16.35	9.52	26.59	18.81	95.91
Current Unearned Revenue	91.41	122.97	108.44	17,869	21,686	18,561
Other Current Liabilities	204.34	183.3	199.78	16,944	14,217	15,673
Total Current Liabilities	879.66	1,106	2,402	50,606	51,093	50,486
Long-Term Debt	-	44.55	665.04	2,215	3,751	4,427
Long-Term Leases	8.08	7.53	12.98	21.37	7.69	-
Long-Term Unearned Revenue	52.47	51.23	55.18	55.63	59.17	53.45
Long-Term Deferred Tax Liabilities	2	2.31	2.73	8.55	5.24	6.54
Other Long-Term Liabilities	-	-	-	-	-	7.95
Total Liabilities	942.21	1,212	3,138	52,907	54,916	54,981
Common Stock	1,017	1,017	1,017	1,017	1,009	1,009
Additional Paid-In Capital	614.02	612.86	612.51	617.8	616.38	40.68
Retained Earnings	2,556	2,475	2,385	2,082	2,202	2,130
Comprehensive Income & Other	-	-	0.29	0.33	900	900
Total Common Equity	4,187	4,105	4,015	3,717	4,727	4,080
Minority Interest	702.18	683.47	665.37	1,850	1,773	2,437
Shareholders' Equity	4,889	4,788	4,680	5,567	6,500	6,517
Total Liabilities & Equity	5,831	6,000	7,818	58,474	61,415	61,499
Total Debt	200.07	285.92	2,182	7,735	9,287	11,468
Net Cash (Debt)	2,551	2,662	-448.16	-3,417	-4,149	-6,394
Net Cash Per Share	2.50	2.62	-0.44	-3.01	-4.01	-6.31
Filing Date Shares Outstanding	1,017	1,017	1,017	1,017	1,009	1,009
Total Common Shares Outstanding	1,017	1,017	1,017	1,017	1,009	1,009
Working Capital	3,089	3,037	3,583	5,023	7,577	8,631
Book Value Per Share	4.12	4.04	3.95	3.66	3.79	3.15
Tangible Book Value	3,869	3,788	3,712	3,365	4,357	3,700
Tangible Book Value Per Share	3.81	3.73	3.65	3.31	3.43	2.77
Buildings	-	1,045	917	1,312	1,294	1,009
Machinery	-	681.06	620.81	604.52	551.66	436.84
Construction In Progress	-	16.12	131.36	72.95	40.99	247.05

Source: S&P Global Market Intelligence. Standard template. Financial Sources.